Concepedia

M.A. Naughton

MN

4

Publications

972

Citations

4

H-Index

1992

Active since

Affiliations

VIR Biotechnology (United States)(Current)

M.A. Naughton is an author at VIR Biotechnology (United States) specializing in pharmacotherapy, natural sciences, and drug development.

Top concepts

Publications per year

1992–1997

4

Publications

4

Design of potent and specific integrin antagonists. Peptide antagonists with high specificity for glycoprotein IIb-IIIa.

Robert M. Scarborough, M.A. Naughton, Wei-Ning Teng et al. · Journal of Biological Chemistry · 1993 · 371 citations · Full text

Characterization of the integrin specificities of disintegrins isolated from American pit viper venoms.

Robert M. Scarborough, Jack W. Rose, M.A. Naughton et al. · Journal of Biological Chemistry · 1993 · 293 citations · Full text

Tethered ligand agonist peptides. Structural requirements for thrombin receptor activation reveal mechanism of proteolytic unmasking of agonist function.

R. M. Scarborough, M.A. Naughton, Willy Teng et al. · Journal of Biological Chemistry · 1992 · 290 citations · Full text

Fibrinogen Receptor (GPIIb-IIIa) Antagonists Derived from 5,6-Bicyclic Templates. Amidinoindoles, Amidinoindazoles, and Amidinobenzofurans Containing the <i>N</i>-α-Sulfonamide Carboxylic Acid Function as Potent Platelet Aggregation Inhibitors

Ting Su, M.A. Naughton, Mark S. Smyth et al. · Journal of Medicinal Chemistry · 1997 · 18 citations · Full text

, , +18

Rows per page

1–4 of 4